resulting in an economic burden of $52 billion per year3. Thus far, no drugs can reverse or stop the progression caused by the disease4. A key difficulty in PD drug development and disease management is the lack of effective
Difficulty with swallowing; Known or been diagnosed to have insomnia; Known or suspected of having neurological disorders that may mediate SDB; Known or suspected of having cardiovascular conditions that may increase patient risk during the study. ...